Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses
- 1 June 1996
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 27 (7) , 1698-1703
- https://doi.org/10.1016/0735-1097(96)00072-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pregnancy and prosthetic heart valvesThe Lancet, 1994
- Outcome of pregnancy in women with valve prostheses.Heart, 1994
- Use of Antithrombotic Agents During PregnancyChest, 1992
- Heparin Therapy During PregnancyArchives of internal medicine (1960), 1989
- Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valvesJournal of the American College of Cardiology, 1986
- Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart ValvesNew England Journal of Medicine, 1986
- Combined use of warfarin and adjusted subcutaneous heparin during pregnancy in patients with an artificial heart valveJournal of the American College of Cardiology, 1986
- The Hypercoagulable StatesAnnals of Internal Medicine, 1985
- Maternal and fetal sequelae of anticoagulation during pregnancyThe American Journal of Medicine, 1980
- Pregnancy and its complications following cardiac valve prosthesesAmerican Journal of Obstetrics and Gynecology, 1978